logo

Strongbridge Biopharma Plc (SBBP)



Trade SBBP now with
  Date
  Headline
11/14/2017 7:34:38 AM Strongbridge Biopharma Q3 Net Loss Attributable To Ordinary Shareholders $35.1 Mln Or $0.98 Per Share
10/3/2017 4:04:32 PM Strongbridge Biopharma Announces Proposed Public Offering Of Ordinary Shares
7/17/2017 7:36:47 AM Strongbridge Biopharma Plc Secures $53 Mln Financing From CRG
6/27/2017 7:44:24 AM Strongbridge Biopharma Completes Target Enrollment Of 90 Patients In The Phase 3 SONICS Study Evaluating RECORLEV
5/16/2017 7:39:27 AM Strongbridge Biopharma Provides Corporate Update; Posts Q1 Net Loss Attributable To Shareholders $29.5 Mln Or $0.83/shr
3/27/2017 7:36:25 AM Strongbridge Biopharma 2016 Net Loss Attributable To Ordinary Shareholders $48.6 Mln Vs Loss $49.2 Mln Last Year
12/29/2016 9:03:53 AM Strongbridge Biopharma Announces Closing Of $35 Mln Equity Financing And $40 Mln Credit Facility
12/23/2016 8:16:51 AM Strongbridge Biopharma Q2 Loss Attributable To Shareholders $12.8 Mln Or $0.61/shr Vs $17.1 Mln Or $1.19/shr Last Year
12/23/2016 8:03:35 AM Strongbridge Biopharma Announces $35 Mln Equity Financing